Abstract
Breast cancer is the most common malignancy in women in the United States, with over 130,000 new cases developing annually(1). Despite improved methods for early detection and treatment, the death rate from breast cancer in the United States has not changed over tbe past 25 years. Nearly all patients who die from breast cancer do so as a result of widespread systemic metastases. Metastatic breast cancer is difficult to detect early and impossible to cure with currently available treatment modalities.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
E. Silverberg and J. A. Lubera, Cancer statistics,Ca — A Journal for Clinicians. 38:5–22(1988).
R.L. Ceriani, K.E. Thompson, J.A. Peterson, and S. Abrahm, Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc. Natl. Acad. Sci(USA) 74:582–586(1977).
J. Arklie, J. Taylor-Papadimitriou, W. F. Bodner, M. Eagan, and R. Mills, Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancer,Int. J. Cancer 28:23–29(1981).
D. Hofheinz, D. Dienhart, G. Miller,et al., Monoclonal antibody, KC4G3, recognizes a novel, widely expresssed antigen on human epithelial cancers,Proc. Am. Assoc. Cancer. Res. 28:1552(1987).
R. L. Ceriani, J. A. Peterson, L. Y. Lee, F. R. Moncada, and E. W. Blank, Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule,Som. Cell Genet. 9:415–527(1983).
J. Taylor-Papadimitriou, J. A. Peterson, J. Arklie, J. Burchell, R. L. Ceriani, and W. F. Bodner, Monoclonal antibodies to epithelium-specific components of human milk fat globule membrane production and reaction with cells in culture,Int. J. Cancer. 28:17–24(1981).
R. L. Ceriani, E.H. Rosenbaum, M. Chandler, T.T. Trujillo, B. Myers and M. Sakada, Role of circulating human mammary epithelial antigens(HME-Ags) as serum markers for breast cancer. In “Tumor markers and their significance in the management of breast cancer.” IP, C.. ed. A.R. Liss. ed.. 1986. pp.3–19.
F. C. Greenwood, W. M. Hunter and J.S. Glover, The preparation of 131-I-labeled human growth hormone of high specific activity,Biochem J. 89:114–119(1963).
T. Lindmo, E. Boven, F. Cuttitta, J. Fedorko, and P.A. Bunn Jr., Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess,J. Immunol. Methods. 72:77–86(1984).
R. D. Brown and J. E. Manno, ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimations in pharmacokinetics,J. Pharm. Sci. 67:1687–1691(1979).
H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff, Statistical estimations in pharmacokinetics,J. Pharmacokinet. Biopharmaceut. 2:123–148(1974).
A. H. Epenetos, S. Mather, M. Granowska,et al., Targeting of iodine-123-labeled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors,Lancet 2:99–1006(1982).
R. M. Rainsbury, J. H. Westwood, R. C. Coomlees, and A. M. Neville, Location of metastatic breast carcinoma by a monoclonal antibody chelate labeled with indium-111,Lancet 2:934–938(1983).
H. P. Kalofonos, G. B. Sivolopenko, N. I. Courteney-Luck,et al., Antibody guided targeting of non-small cell lung cancer using 111-In-labeled HMFG1 F(ab’)2 fragments,Cancer Res 48:1977–1984(1988).
A. A. Epenetos, D. Snook, H. Durbin, P. M. Johnson, and J. Taylor-Papadimitriou, Limitation of radiolabeled monoclonal antibodies for localization of human neoplasms,Cancer Res. 46:3183–3191(1986).
M. Granowska, K. E. Britton, J. H. Shepherd,et al., A prospective study of 123Ilabeled monoclonal antibody imaging in ovarian cancer,J. Clin. Oncol. 4:730–736(1986).
D. Dienhart, R. Schmelter, J. Lear,et al., Imaging and treatment of non-small cell lung cancer with monoclonal antibody KC4G3,Proc. Am. Soc. Clin. Oncol. 6:184(1987).
S. T. Rosen, A. M. Zimmer, R. Goldman,et al., Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using 131-I labeled monoclonal antibody: An Illinois Cancer Council study,J. Clin. Oncol. 5:562–573(1987).
S. E. Order, G. B. Stillwagon, J. L. Klein,et al., Iodine 131 antiferritin, a new treatment modality in hepatoma: A radiation therapy oncology group study, J. Clin. Oncol. 3:1573–1582(1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bunn, P.A. et al. (1989). In Vivo Studies of Radiolabeled Monoclonal Antibodies Mc5 and KC4 in Human Breast Cancer. In: Ceriani, R.L. (eds) Breast Cancer Immunodiagnosis and Immunotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1296-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1296-4_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1298-8
Online ISBN: 978-1-4757-1296-4
eBook Packages: Springer Book Archive